Pure Global AI
Disease / condition

Pulmonary Hypertension clinical trials

Free access to 283 studies10+ countriesUpdated daily52 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
283
Total trials
10+
Countries
10+
Sponsors
52
Recruiting
By phase
N/A171
Phase 335
Phase 231
Phase 416
Early Phase 115
By status
Completed147
Recruiting52
Unknown27
Terminated22
Not yet recruit...22
Top countries
United States of America61
China22
Switzerland21
Germany15
United Kingdom14
Top sponsors
University of Zuri...22
Actelion9
United Therapeutic...8
Medical University...8
Bayer7
Recent trials
Latest clinical trials for Pulmonary Hypertension
Association Between Biomarkers and eGFR Decline in Pulmonary Hypertension
University of Giessen · Germany
NCT06409624Recruiting
Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
Royal United Hospitals Bath NH... · United Kingdom
NCT06386185Not yet recr...
Circulating MrgD in Pulmonary Hypertension
Qilu Hospital of Shandong Univ... · China
NCT06365372Recruiting
Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
China-Japan Friendship Hospita... · China
NCT06362382Not yet recr...
A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia
Duke University · United States of America
NCT06327373Not yet recr...
Phase
Phase 1/2
CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy, CHASE Study
Chinese Pulmonary Vascular Dis...
NCT06135909Not yet recr...
ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and Echo
Royal United Hospitals Bath NH... · United Kingdom
NCT06145880Not yet recr...
Pulmonaryhypertension in Copd at Different Levels of Smoking
Assiut University
NCT06031311Not yet recr...
Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension
ADIR Association
NCT06079151Not yet recr...
Levosimendan in Pulmonary Hypertension Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Tenax Therapeutics, Inc.
NCT05983250Not yet recr...
Phase
Phase 3
Pulmonary Hypertension Observational Study
The First Affiliated Hospital ... · China
NCT05958901Recruiting
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
University of Giessen · Germany
NCT05935865Recruiting
Improving Pulmonary Hypertension Screening by Echocardiography
Royal United Hospitals Bath NH... · United Kingdom
NCT06038149Not yet recr...
Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension
Power Life Sciences Inc. · United States of America
NCT05918458Not yet recr...
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Eko Devices, Inc. · United States of America
NCT05873387Recruiting
Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary Hypertension
Dokuz Eylul University · Turkey
NCT05901168Not yet recr...
PIMR and Pulmonary Vascular Disease
University of California, Los ... · United States of America
NCT05843461Recruiting
Novel Index (PIMR) in PAH
University of California, Los ... · United States of America
NCT05812976Recruiting
A Phase 2a Study of LAM-001 for the Treatment of PH
AI Therapeutics, Inc. · United States of America
NCT05798923Recruiting
Phase
Phase 2
Untitled Trial
jRCTs031220640Recruiting
About this profile

Access comprehensive clinical trial information for Pulmonary Hypertension through Pure Global AI's free database. This collection includes 283 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 52 trials are actively recruiting participants.

Research for Pulmonary Hypertension is being conducted in United States of America, China, Switzerland and 7+ other countries. Leading sponsors include University of Zurich and Actelion. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 283 clinical trials studying Pulmonary Hypertension, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include University of Zurich, Actelion, United Therapeutics, among others.